Department of Health and Human Services May 1, 2009 – Federal Register Recent Federal Regulation Documents

Medicare Program; Inpatient Psychiatric Facilities Prospective Payment System Payment Update for Rate Year Beginning July 1, 2009 (RY 2010)
Document Number: E9-9962
Type: Notice
Date: 2009-05-01
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This notice updates the payment rates for the Medicare prospective payment system (PPS) for inpatient psychiatric hospital services provided by inpatient psychiatric facilities (IPFs). These changes are applicable to IPF discharges occurring during the rate year beginning July 1, 2009 through June 30, 2010. We are also requesting comments on the IPF PPS teaching adjustment and the market basket.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: E9-9959
Type: Notice
Date: 2009-05-01
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: E9-9957
Type: Notice
Date: 2009-05-01
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
Proposed Information Collection Activity; Comment Request
Document Number: E9-9900
Type: Notice
Date: 2009-05-01
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Establishment of the Children's Health Insurance Program Working Group and Request for Nominations for Members
Document Number: E9-10083
Type: Notice
Date: 2009-05-01
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Employee Benefits Security Administration, Department of Labor
This notice announces the establishment of the Children's Health Insurance Program Working Group and discusses the group's purpose and charter. It also solicits nominations for members.
Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC)
Document Number: E9-10051
Type: Notice
Date: 2009-05-01
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Guidance for Industry: Small Entities Compliance Guide for Renderers-Substances Prohibited From Use in Animal Food or Feed; Availability
Document Number: E9-10034
Type: Notice
Date: 2009-05-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry 195 entitled ``Small Entities Compliance Guide for RenderersSubstances Prohibited From Use in Animal Food or Feed'' This small entities compliance guide aids renderers in complying with the requirements of the final rule published in the Federal Register of April 25, 2008 (73 FR 22720). FDA's goal is to strengthen existing safeguards to prevent the spread of bovine spongiform encephalopathy (BSE) in U.S. cattle and to reduce the risk of human exposure to the BSE agent.
National Center for Injury Prevention and Control, Initial Review Group (NCIPC, IRG)
Document Number: E9-10031
Type: Notice
Date: 2009-05-01
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
National Center for Injury Prevention and Control, Initial Review Group (NCIPC, IRG)
Document Number: E9-10028
Type: Notice
Date: 2009-05-01
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Information Collection Activity; Comment Request
Document Number: E9-10021
Type: Notice
Date: 2009-05-01
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Submission for OMB Review; Comment Request
Document Number: E9-10020
Type: Notice
Date: 2009-05-01
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Center for Scientific Review; Amended Notice of Meeting
Document Number: E9-10019
Type: Notice
Date: 2009-05-01
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Document Number: E9-10018
Type: Notice
Date: 2009-05-01
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Document Number: E9-10017
Type: Notice
Date: 2009-05-01
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Document Number: E9-10013
Type: Notice
Date: 2009-05-01
Agency: Department of Health and Human Services, National Institutes of Health
Proposed Collection; Comment Request; Collection of Customer Service, Demographic, and Smoking/Tobacco Use Information From NCI Cancer Information Service (CIS) Clients (NCI)
Document Number: E9-10012
Type: Notice
Date: 2009-05-01
Agency: Department of Health and Human Services, National Institutes of Health
In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute (NCI), the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Public Consultation Meeting of the Working Group on Strengthening the Biosecurity of the United States
Document Number: E9-10008
Type: Notice
Date: 2009-05-01
Agency: Department of Health and Human Services
The U.S. Department of Health and Human Services is hereby giving notice that the Working Group on Strengthening the Biosecurity of the United States will be holding a public consultation meeting. The meeting is open to the public.
Draft Guidance for Industry on Label Comprehension Studies for Nonprescription Drug Products; Availability
Document Number: E9-10005
Type: Notice
Date: 2009-05-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Label Comprehension Studies for Nonprescription Drug Products.'' The draft guidance provides recommendations on the design of label comprehension studies, which can be used to assess the extent to which consumers understand the information conveyed by proposed nonprescription drug product labeling and then apply that information when making hypothetical drug product use decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.